202 related articles for article (PubMed ID: 15482349)
1. Halofuginone can worsen liver fibrosis in bile duct obstructed rats.
Van de Casteele M; Roskams T; Van der Elst I; van Pelt JF; Fevery J; Nevens F
Liver Int; 2004 Oct; 24(5):502-9. PubMed ID: 15482349
[TBL] [Abstract][Full Text] [Related]
2. Effects of selective bile duct ligation on liver parenchyma in young animals: histologic and molecular evaluations.
Tannuri AC; Coelho MC; de Oliveira Gonçalves J; Santos MM; Ferraz da Silva LF; Bendit I; Tannuri U
J Pediatr Surg; 2012 Mar; 47(3):513-22. PubMed ID: 22424347
[TBL] [Abstract][Full Text] [Related]
3. Silymarin retards collagen accumulation in early and advanced biliary fibrosis secondary to complete bile duct obliteration in rats.
Boigk G; Stroedter L; Herbst H; Waldschmidt J; Riecken EO; Schuppan D
Hepatology; 1997 Sep; 26(3):643-9. PubMed ID: 9303494
[TBL] [Abstract][Full Text] [Related]
4. Low-dose oral rapamycin treatment reduces fibrogenesis, improves liver function, and prolongs survival in rats with established liver cirrhosis.
Neef M; Ledermann M; Saegesser H; Schneider V; Reichen J
J Hepatol; 2006 Dec; 45(6):786-96. PubMed ID: 17050028
[TBL] [Abstract][Full Text] [Related]
5. [Serum hyaluronic acid level: correlation with quantitative measurement of hepatic fibrosis in a cirrhotic rat model].
Kim MY; Baik SK; Jang YO; Suk KT; Kim JW; Kim HS; Cho MY; Choi SJ; Um SH; Han KH
Korean J Hepatol; 2008 Jun; 14(2):159-67. PubMed ID: 18617763
[TBL] [Abstract][Full Text] [Related]
6. [Morphopathological changes before and after biliodigestive derivation in experimental cirrhosis induced by biliary ligation in the rat].
Marinelli Ibarreta A; Sánchez Movilla A; Izquierdo F; Burgos Lázaro F; Arce Alvarez A; del Castillo-Olivares Ramos JL
Rev Esp Enferm Dig; 1995 Jan; 87(1):25-31. PubMed ID: 7727164
[TBL] [Abstract][Full Text] [Related]
7. Octreotide inhibits hepatic fibrosis, bile duct proliferation and bacterial translocation in obstructive jaundice.
Türkçapar N; Bayar S; Koyuncu A; Ceyhan K
Hepatogastroenterology; 2003; 50(51):680-3. PubMed ID: 12828059
[TBL] [Abstract][Full Text] [Related]
8. Long-term administration of aqueous garlic extract (AGE) alleviates liver fibrosis and oxidative damage induced by biliary obstruction in rats.
Gedik N; Kabasakal L; Sehirli O; Ercan F; Sirvanci S; Keyer-Uysal M; Sener G
Life Sci; 2005 Apr; 76(22):2593-606. PubMed ID: 15769483
[TBL] [Abstract][Full Text] [Related]
9. Reversibility of hepatic fibrosis in experimentally induced cholestasis in rat.
Abdel-Aziz G; Lebeau G; Rescan PY; Clément B; Rissel M; Deugnier Y; Campion JP; Guillouzo A
Am J Pathol; 1990 Dec; 137(6):1333-42. PubMed ID: 2260623
[TBL] [Abstract][Full Text] [Related]
10. Modified synthetic siRNA targeting tissue inhibitor of metalloproteinase-2 inhibits hepatic fibrogenesis in rats.
Hu YB; Li DG; Lu HM
J Gene Med; 2007 Mar; 9(3):217-29. PubMed ID: 17351970
[TBL] [Abstract][Full Text] [Related]
11. Chronic bile duct obstruction induces changes in plasma and hepatic levels of cytokines and nitric oxide in the rat.
Fernández-Martínez E; Pérez-Alvarez V; Tsutsumi V; Shibayama M; Muriel P
Exp Toxicol Pathol; 2006 Aug; 58(1):49-58. PubMed ID: 16617007
[TBL] [Abstract][Full Text] [Related]
12. The effect of halofuginone, a specific inhibitor of collagen type 1 synthesis, in the prevention of pancreatic fibrosis in an experimental model of severe hyperstimulation and obstruction pancreatitis.
Karatas A; Paksoy M; Erzin Y; Carkman S; Gonenc M; Ayan F; Aydogan F; Uzun H; Durak H
J Surg Res; 2008 Jul; 148(1):7-12. PubMed ID: 18570924
[TBL] [Abstract][Full Text] [Related]
13. Biliary fibrosis in microsurgical extrahepatic cholestasis in the rat.
Sánchez-Patán F; Anchuelo R; Corcuera MT; Casado I; Gómez-Aguado F; Aller MA; Cruz A; Alonso MJ; Arias J
Microsurgery; 2008; 28(5):361-6. PubMed ID: 18561272
[TBL] [Abstract][Full Text] [Related]
14. Local inhibition of liver fibrosis by specific delivery of a platelet-derived growth factor kinase inhibitor to hepatic stellate cells.
Gonzalo T; Beljaars L; van de Bovenkamp M; Temming K; van Loenen AM; Reker-Smit C; Meijer DK; Lacombe M; Opdam F; Kéri G; Orfi L; Poelstra K; Kok RJ
J Pharmacol Exp Ther; 2007 Jun; 321(3):856-65. PubMed ID: 17369283
[TBL] [Abstract][Full Text] [Related]
15. [Changes of hepatic blood flow and intrahepatic microvascular bed in rats with chronic biliary obstruction].
Chen XS
Zhonghua Wai Ke Za Zhi; 1992 Dec; 30(12):751-4, 780. PubMed ID: 1339754
[TBL] [Abstract][Full Text] [Related]
16. Herb medicine Yin-Chen-Hao-Tang ameliorates hepatic fibrosis in bile duct ligation rats.
Lee TY; Chang HH; Chen JH; Hsueh ML; Kuo JJ
J Ethnopharmacol; 2007 Jan; 109(2):318-24. PubMed ID: 16989967
[TBL] [Abstract][Full Text] [Related]
17. Halofuginone reduces the occurrence of renal fibrosis in 5/6 nephrectomized rats.
Benchetrit S; Yarkoni S; Rathaus M; Pines M; Rashid G; Bernheim J; Bernheim J
Isr Med Assoc J; 2007 Jan; 9(1):30-4. PubMed ID: 17274353
[TBL] [Abstract][Full Text] [Related]
18. Effect of losartan, an angiotensin II antagonist, on secondary biliary cirrhosis.
Ramalho LN; Ramalho FS; Zucoloto S; Castro-e-Silva Júnior O; Corrêa FM; Elias Júnior J; Magalhães JF
Hepatogastroenterology; 2002; 49(48):1499-502. PubMed ID: 12397717
[TBL] [Abstract][Full Text] [Related]
19. LPS signaling enhances hepatic fibrogenesis caused by experimental cholestasis in mice.
Isayama F; Hines IN; Kremer M; Milton RJ; Byrd CL; Perry AW; McKim SE; Parsons C; Rippe RA; Wheeler MD
Am J Physiol Gastrointest Liver Physiol; 2006 Jun; 290(6):G1318-28. PubMed ID: 16439470
[TBL] [Abstract][Full Text] [Related]
20. The biological response modifier AM3 attenuates the inflammatory cell response and hepatic fibrosis in rats with biliary cirrhosis.
Albillos A; Nieto M; Ubeda M; Muñoz L; Fraile B; Reyes E; Lledó L; Blanco I; Pastor O; Salas C; Lario M; Monserrat J; Bataller R; Alvarez-Mon M
Gut; 2010 Jul; 59(7):943-52. PubMed ID: 20442198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
